A cytotoxic cycle triggered by DNA single-strand breakage and poly (ADP-ribose) synthetase activation has been shown to contribute to the cellular injury during various forms of oxidant stress in vitro. The aim of this study was to investigate the role of poly (ADP-ribose) synthetase (PARS) in the process of neutrophil recruitment and in development of local and systemic inflammation. In pharmacological studies, PARS was inhibited by 3-aminobenzamide (10–20 mg/kg) in rats and mice. In other sets of studies, inflammatory responses in PARS−/− mice were compared with the responses in corresponding wild-type controls. Inhibition of PARS reduced neutrophil recruitment and reduced the extent of edema in zymosan- and carrageenan-triggered models of local inflammation. Moreover, inhibition of PARS prevented neutrophil recruitment, and reduced organ injury in rodent models of inflammation and multiple organ failure elicited by intraperitoneal injection of zymosan. Inhibition of PARS also reduced the extent of neutrophil emigration across murine mesenteric postcapillary venules. This reduction was due to an increased rate of adherent neutrophil detachment from the endothelium, promoting their reentry into the circulation. Taken together, our results demonstrate that PARS inhibition reduces local and systemic inflammation. Part of the antiinflammatory effects of PARS inhibition is due to reduced neutrophil recruitment, which may be related to maintained endothelial integrity.
Skip Nav Destination
Article navigation
6 October 1997
Article|
October 06 1997
Inhibition of poly (ADP-ribose) Synthetase Attenuates Neutrophil Recruitment and Exerts Antiinflammatory Effects
Csaba Szabó,
Csaba Szabó
From the *Children's Hospital Medical Center, Division of Critical Care, Cincinnati, Ohio 45229; and ‡Department of Biochemical Pharmacology, The William Harvey Research Institute, London EC1M6BQ, United Kingdom
Search for other works by this author on:
Lina H.K. Lim,
Lina H.K. Lim
From the *Children's Hospital Medical Center, Division of Critical Care, Cincinnati, Ohio 45229; and ‡Department of Biochemical Pharmacology, The William Harvey Research Institute, London EC1M6BQ, United Kingdom
Search for other works by this author on:
Salvatore Cuzzocrea,
Salvatore Cuzzocrea
From the *Children's Hospital Medical Center, Division of Critical Care, Cincinnati, Ohio 45229; and ‡Department of Biochemical Pharmacology, The William Harvey Research Institute, London EC1M6BQ, United Kingdom
Search for other works by this author on:
Stephen J. Getting,
Stephen J. Getting
From the *Children's Hospital Medical Center, Division of Critical Care, Cincinnati, Ohio 45229; and ‡Department of Biochemical Pharmacology, The William Harvey Research Institute, London EC1M6BQ, United Kingdom
Search for other works by this author on:
Basilia Zingarelli,
Basilia Zingarelli
From the *Children's Hospital Medical Center, Division of Critical Care, Cincinnati, Ohio 45229; and ‡Department of Biochemical Pharmacology, The William Harvey Research Institute, London EC1M6BQ, United Kingdom
Search for other works by this author on:
Roderick J. Flower,
Roderick J. Flower
From the *Children's Hospital Medical Center, Division of Critical Care, Cincinnati, Ohio 45229; and ‡Department of Biochemical Pharmacology, The William Harvey Research Institute, London EC1M6BQ, United Kingdom
Search for other works by this author on:
Andrew L. Salzman,
Andrew L. Salzman
From the *Children's Hospital Medical Center, Division of Critical Care, Cincinnati, Ohio 45229; and ‡Department of Biochemical Pharmacology, The William Harvey Research Institute, London EC1M6BQ, United Kingdom
Search for other works by this author on:
Mauro Perretti
Mauro Perretti
From the *Children's Hospital Medical Center, Division of Critical Care, Cincinnati, Ohio 45229; and ‡Department of Biochemical Pharmacology, The William Harvey Research Institute, London EC1M6BQ, United Kingdom
Search for other works by this author on:
Csaba Szabó
From the *Children's Hospital Medical Center, Division of Critical Care, Cincinnati, Ohio 45229; and ‡Department of Biochemical Pharmacology, The William Harvey Research Institute, London EC1M6BQ, United Kingdom
Lina H.K. Lim
From the *Children's Hospital Medical Center, Division of Critical Care, Cincinnati, Ohio 45229; and ‡Department of Biochemical Pharmacology, The William Harvey Research Institute, London EC1M6BQ, United Kingdom
Salvatore Cuzzocrea
From the *Children's Hospital Medical Center, Division of Critical Care, Cincinnati, Ohio 45229; and ‡Department of Biochemical Pharmacology, The William Harvey Research Institute, London EC1M6BQ, United Kingdom
Stephen J. Getting
From the *Children's Hospital Medical Center, Division of Critical Care, Cincinnati, Ohio 45229; and ‡Department of Biochemical Pharmacology, The William Harvey Research Institute, London EC1M6BQ, United Kingdom
Basilia Zingarelli
From the *Children's Hospital Medical Center, Division of Critical Care, Cincinnati, Ohio 45229; and ‡Department of Biochemical Pharmacology, The William Harvey Research Institute, London EC1M6BQ, United Kingdom
Roderick J. Flower
From the *Children's Hospital Medical Center, Division of Critical Care, Cincinnati, Ohio 45229; and ‡Department of Biochemical Pharmacology, The William Harvey Research Institute, London EC1M6BQ, United Kingdom
Andrew L. Salzman
From the *Children's Hospital Medical Center, Division of Critical Care, Cincinnati, Ohio 45229; and ‡Department of Biochemical Pharmacology, The William Harvey Research Institute, London EC1M6BQ, United Kingdom
Mauro Perretti
From the *Children's Hospital Medical Center, Division of Critical Care, Cincinnati, Ohio 45229; and ‡Department of Biochemical Pharmacology, The William Harvey Research Institute, London EC1M6BQ, United Kingdom
Address correspondence to Dr. Csaba Szabó, Children's Hospital Medical Center, Division of Critical Care, 3333 Burnet Avenue, Cincinnati, OH 45229. Phone: 513-636-8714; FAX: 513-636-4892.
1
Abbreviations used in this paper: AST, aspartate aminotransferase; LDH, lactate dehydrogenase; MPO, myeloperoxidase; PARS, poly (ADP-ribose) synthetase.
Received:
May 23 1997
Revision Received:
July 29 1997
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1997
J Exp Med (1997) 186 (7): 1041–1049.
Article history
Received:
May 23 1997
Revision Received:
July 29 1997
Citation
Csaba Szabó, Lina H.K. Lim, Salvatore Cuzzocrea, Stephen J. Getting, Basilia Zingarelli, Roderick J. Flower, Andrew L. Salzman, Mauro Perretti; Inhibition of poly (ADP-ribose) Synthetase Attenuates Neutrophil Recruitment and Exerts Antiinflammatory Effects . J Exp Med 6 October 1997; 186 (7): 1041–1049. doi: https://doi.org/10.1084/jem.186.7.1041
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement